Post by Brian Yang
Journalist, cross-cultural interpreter of US-China biotech, policy and human impact
For Fu, the path forward for China is clear: less emphasis on quantity and a greater commitment to originality, basic research, and quality. Until then, he argues, the hunt for true innovation in China continues.
